GTC BIOTHERAPEUTICS INC 4
4 · GTC BIOTHERAPEUTICS INC · Filed Sep 30, 2003
Insider Transaction Report
Form 4
MEADE HARRY
SVP, Transgenic Research
Transactions
- Other
Common Stock
2003-09-26$2.34/sh+1,216$2,842→ 34,226 total
Holdings
- 7,916.317(indirect: By 401(k))
Common Stock
- 653(indirect: By Son)
Common Stock
Footnotes (2)
- [F1]Shares acquired through Issuer's Employee Stock Purchase Plan, a Rule 16b-3 plan.
- [F2]The reporting person disclaims beneficial ownership of 653 shares of common stock held indirectly by his adult son in his 401(k) Plan, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.